Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 204

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 204
---
 |        |     28,764 |   |
| Cash and cash equivalents, end of year                              |     | $            |    457,740 |   |     | $      |     54,104 |   |     |        |     27,556 |   |
| Supplementary cash flow information:                                |     |              |            |   |     |        |            |   |     |        |            |   |
| Taxes paid                                                          |     | $            |          — |   |     | $      |          — |   |     |        |    (12,170 | ) |
| Interest paid                                                       |     | $            |   (768,068 | ) |     | $      |    (24,704 | ) |     |        |    (55,469 | ) |

| ** | Re-presented as mentioned in Note 23 |

During the year ended December 31, 2024, no cash was exchanged in
respect of these transactions:

| a. | $2,650,000 of convertible debt was converted into equity. |

| b. | Reversal arising from remeasurement 
 of share-based compensation within  
 prepayment amounting to $2,739,856. |

<div align='center'>The accompanying notes are an integral part of
these consolidated financial statements.

F-8

NEWGENIVF GROUP LIMITED
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
FOR THE YEARS ENDED DECEMBER 31, 2024, 2023 AND 2022
(Stated in US Dollars)</div>

NOTE 1 — ORGANIZATION AND PRINCIPAL ACTIVITIES

Prior to the Business Combination,
on April 29, 2021, A SPAC I Acquisition Corp. (“ASCA”), was incorporated as a British Virgin Islands business company, specifically
a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization,
reorganization or similar business combination with one or more target businesses.

The Business Combination

On February 15, 2023, ASCA
entered into the Merger Agreement (as amended on June 12, 2023 and December 6, 2023, the “Merger Agreement,” and the transactions
contemplated thereunder, the “Business Combination”) with A SPAC I Mini Acquisition Corp., Merger Sub, NewGenIvf Limited,
a Cay